array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Novartis Gene Therapies, Inc." ["slug"]=> string(19) "a26d9-us-avexis-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/35cea00f-69c0-468d-b166-ddd4f49dfa0c" ["description"]=> string(639) "Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. Around 108,000 people of more than 140 nationalities work at Novartis around the world. See our community guidelines: http://bit.ly/2JnT2CP" ["address_street"]=> string(24) "2275 Half Day Rd Ste 200" ["address_place"]=> string(11) "Bannockburn" ["address_region"]=> string(8) "Illinois" ["founding_date"]=> string(10) "2010-02-28" ["website_domain"]=> string(12) "novartis.com" ["website_url"]=> string(24) "https://www.novartis.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(219) ["article_count"]=> int(7829) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(88) "Matterworks Appoints Jennifer Campbell Chief Scientific Officer and Niall O’Connor CTO" ["snippet_en"]=> string(179) "Matterworks, Inc., whose foundational AI platform and predictive biology applications accelerate life sciences discovery and development, today announces additions to... Read More" ["url"]=> string(124) "https://www.citybiz.co/article/550497/matterworks-appoints-jennifer-campbell-chief-scientific-officer-and-niall-oconnor-cto/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3eac8232-dc43-4304-bdc0-45ce39f6c8db" ["source"]=> string(10) "citybiz.co" ["publication_date"]=> string(10) "2024-05-03" ["categories"]=> array(2) { [0]=> string(5) "R & D" [1]=> string(12) "Board Change" } } [1]=> array(7) { ["title_en"]=> string(55) "Investment ideas from Alpha Rheintal Bank: Novartis (1)" ["snippet_en"]=> string(32) "Price on May 2nd, 2024 CHF 88.87" ["url"]=> string(77) "https://rheintaler.ch/artikel/anlageideen-der-alpha-rheintal-bank-novartis-1/" ["image_url"]=> NULL ["source"]=> string(13) "rheintaler.ch" ["publication_date"]=> string(10) "2024-05-03" ["categories"]=> array(2) { [0]=> string(8) "spin-off" [1]=> string(18) "General Investment" } } [2]=> array(7) { ["title_en"]=> string(37) "Stalicla helps with cocaine addiction" ["snippet_en"]=> string(246) "An active ingredient against cocaine addiction that Novartis has been investigating for some time is making progress in clinical development by the company Stalicla. This had recently licensed in the negative antagonist of the glutamate receptor." ["url"]=> string(72) "https://transkript.de/artikel/2024/stalicla-kommt-bei-kokainsucht-voran/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e5c24a22-e9b1-40a9-bbd7-95ef586ac85c" ["source"]=> string(13) "transkript.de" ["publication_date"]=> string(10) "2024-05-03" ["categories"]=> array(0) { } } [3]=> array(7) { ["title_en"]=> string(76) "Radioligand Therapy: Novartis Set to Acquire Mariana Oncology for $1 Billion" ["snippet_en"]=> string(156) "The objective of the transaction is to strengthen Novartis' RLT pipeline and expand the company's research infrastructure and clinical delivery capabilities" ["url"]=> string(133) "https://www.aboutpharma.com/aziende/terapia-con-radioligandi-novartis-pronta-ad-acquisire-mariana-oncology-per-1-miliardo-di-dollari/" ["image_url"]=> NULL ["source"]=> string(15) "aboutpharma.com" ["publication_date"]=> string(10) "2024-05-02" ["categories"]=> array(2) { [0]=> string(18) "Expansion & Growth" [1]=> string(11) "Acquisition" } } [4]=> array(7) { ["title_en"]=> string(95) "Pharmaceutical company Novartis will buy Mariana Oncology with an advance payment of $1 billion" ["snippet_en"]=> string(143) "Swiss pharmaceutical company Novartis will buy American biotechnology company Mariana Oncology, paying an advance of $1 billion, Novartis said." ["url"]=> string(80) "https://www.vedomosti.ru/business/news/2024/05/02/1035131-farmkompaniya-novartis" ["image_url"]=> string(78) "https://images.businessradar.com/articles/acd34244-3da7-48b7-92bb-3196e3440724" ["source"]=> string(12) "vedomosti.ru" ["publication_date"]=> string(10) "2024-05-02" ["categories"]=> array(0) { } } [5]=> array(7) { ["title_en"]=> string(27) "Breast cancer and sexuality" ["snippet_en"]=> string(128) "The León Hospital has held the workshop 'Living sexuality after breast cancer' to address the impact on patients' sexual lives." ["url"]=> string(140) "https://www.somospacientes.com/noticias/carrusel-de-portada/formulas-para-que-las-pacientes-de-cancer-de-mama-puedan-mejorar-su-vida-sexual/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0b9b3aab-8e50-4265-b4ea-669e88213d54" ["source"]=> string(18) "somospacientes.com" ["publication_date"]=> string(10) "2024-05-02" ["categories"]=> array(1) { [0]=> string(13) "Collaboration" } } [6]=> array(7) { ["title_en"]=> string(38) "Eternal youth is closer than you think" ["snippet_en"]=> string(152) "Always Young: How much fun is infinite life? What does that do to our perception of time? An exhibition in Basel makes you think about it. The bag is…" ["url"]=> string(89) "https://www.nrc.nl/nieuws/2024/05/02/de-eeuwige-jeugd-is-dichterbij-dan-je-denkt-a4196861" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4441585f-e379-4e83-a126-e35fe5431068" ["source"]=> string(6) "nrc.nl" ["publication_date"]=> string(10) "2024-05-02" ["categories"]=> array(0) { } } [7]=> array(7) { ["title_en"]=> string(32) "Salus tv n. 18 of April 30, 2024" ["snippet_en"]=> string(19) "2024-04-30 21:49:47" ["url"]=> string(66) "https://www.nouvelles-du-monde.com/salus-tv-n-18-du-30-avril-2024/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/9a3a3c40-dfd6-4f60-bfe4-00dc230efe4f" ["source"]=> string(22) "nouvelles-du-monde.com" ["publication_date"]=> string(10) "2024-05-01" ["categories"]=> array(0) { } } [8]=> array(7) { ["title_en"]=> string(91) "More African Countries Roll Out Malaria Vaccine, While Babies Get New Treatment Formulation" ["snippet_en"]=> string(154) "Rollout of malaria vaccines are starting in Benin, Sierra Leone and Liberia, and the West African countries plan to deliver more than 800 000 doses of the" ["url"]=> string(124) "https://healthpolicy-watch.news/more-african-countries-roll-out-malaria-vaccine-while-babies-get-new-treatment-forumulation/" ["image_url"]=> NULL ["source"]=> string(23) "healthpolicy-watch.news" ["publication_date"]=> string(10) "2024-04-30" ["categories"]=> array(1) { [0]=> string(11) "Geopolitics" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(527) } [1]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(450) } [2]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(433) } [3]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(306) } [4]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(302) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(242) } [6]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(238) } [7]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(232) } [8]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(194) } [9]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(189) } [10]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(179) } [11]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(163) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(161) } [13]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(160) } [14]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(143) } [15]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(133) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(130) } [17]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(125) } [18]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(119) } [19]=> array(2) { ["name"]=> string(8) "spin-off" ["count"]=> int(114) } [20]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(112) } [21]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(108) } [22]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(98) } [23]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(98) } [24]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(85) } [25]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(85) } [26]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(81) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(80) } [28]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(78) } [29]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(74) } } } a26d9-us-avexis-inc